Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Prostatic Neoplasms 47Breast Neoplasms 6Leiomyoma 5Neoplasms 4Adenocarcinoma 2Uterine Neoplasms 1Urogenital Neoplasms 1Prostatic Diseases 1Premenopausal Breast Cancer 1Polycystic Ovary Syndrome 1Neoplasms, Glandular and Epithelial 1Neoplasm Metastasis 1Myofibroma 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lower Urinary Tract Symptoms 1Infertility 1Hodgkin Disease 1Hereditary Sensory and Autonomic Neuropathies 1Genital Neoplasms, Male 1Carcinoma 1Breast Neoplasms, Male 1Advanced Prostate Cancer 1Advanced Prostate Adenocarcinoma 1

Interventions

pembrolizumab 4Pemetrexed 3Paclitaxel 3Fulvestrant 2FANG vaccine 2Drug Therapy 2Carboplatin 2tucatinib 1trastuzumab deruxtecan 1seribantumab 1selinexor 1osimertinib 1gedatolisib 1dactolisib 1cobimetinib 1cemiplimab 1atezolizumab 1Watchful Waiting 1Trastuzumab 1Transurethral Resection of Prostate 1Trabectedin 1Therapeutics 1Sutures 1Radiation 1Quality of Life 1Pregnancy Tests 1Patient Reported Outcome Measures 1Oxaliplatin 1OSI 930 1Molecular Diagnostic Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Uterine Neoplasms × Leuprolide × Clear all
NCT00776074 2010-06-22

A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.

Takeda

Phase 2 Completed
80 enrolled
Gynecologic

Leiomyoma, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡